Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies   EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,